Abstract 3390: Predictive and prognostic value of circulating tumor DNA (ctDNA) compared to circulating tumor cells (CTC) in a prospective cohort of metastatic breast cancer patients: The UCBG COMET trial

Cancer Patients ◽

Tumor Cells ◽

Prognostic Value ◽

Metastatic Breast ◽

Circulating Tumor Dna ◽

Breast Cancer Patients ◽

Predictive And Prognostic Value ◽

Abstract PD2-03: Circulating tumor DNA (ctDNA) and circulating tumor cells (CTC) predictive value in HER2 negative metastatic breast cancer patients treated with first line weekly paclitaxel and bevacizumab: Results of a prospective cohort from the French Breast Cancer InterGroup Unicancer (UCBG): COMET study

10.1158/1538-7445.sabcs18-pd2-03 ◽

2019 ◽

Author(s):

J-Y Pierga ◽

A Silveira ◽

V Lorgis ◽

M-L Tanguy ◽

O Tredan ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Predictive Value ◽

Metastatic Breast ◽

Circulating Tumor Dna ◽

Breast Cancer Patients ◽

First Line ◽

Abstract 504: Circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs) are superior to CA 15-3 in predicting tumor burden, patients response to treatment and overall survival (OS) rates in metastatic breast cancer patients from Egypt

10.1158/1538-7445.am2016-504 ◽

2016 ◽

Author(s):

Abdel-Rahman N. Zekri ◽

Abeer A. Bahnassy

Keyword(s):

Breast Cancer ◽

Overall Survival ◽

Cancer Patients ◽

Metastatic Breast ◽

Circulating Tumor Dna ◽

Tumor Burden ◽

Response To Treatment ◽

Breast Cancer Patients ◽

Abstract P1-01-02: Circulating tumor cells (CTC) and endothelial cells (CEC) prognostic value in HER2 negative metastatic breast cancer patients treated with first line weekly paclitaxel and bevacizumab: First results of a prospective cohort from the French Breast Cancer InterGroup Unicancer (UCBG): COMET study

10.1158/1538-7445.sabcs16-p1-01-02 ◽

2017 ◽

Author(s):

J-Y Pierga ◽

O Tredant ◽

M Chevrier ◽

C Dubot ◽

V Lorgis ◽

...

Keyword(s):

Breast Cancer ◽

Endothelial Cells ◽

Cancer Patients ◽

Tumor Cells ◽

Prognostic Value ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line ◽

First Results

Abstract P4-01-06: Comparison of tumor genotyping and cell-free circulating tumor DNA sequencing in metastatic breast cancer patients and their utility in the selection of matched therapy

10.1158/1538-7445.sabcs18-p4-01-06 ◽

2019 ◽

Author(s):

N Vidula ◽

D Juric ◽

A Niemierko ◽

L Spring ◽

B Moy ◽

...

Keyword(s):

Breast Cancer ◽

Dna Sequencing ◽

Cancer Patients ◽

Metastatic Breast ◽

Circulating Tumor Dna ◽

Breast Cancer Patients ◽

Tumor Dna ◽

Tumor Genotyping ◽

Selection Of

The prognostic value of circulating tumor cells lacking cytokeratins in metastatic breast cancer patients

Journal of Cancer Research and Therapeutics ◽

10.4103/0973-1482.110353 ◽

2013 ◽

Vol 9 (1) ◽

pp. 29 ◽

Cited By ~ 3

Author(s):

Li Cai ◽

Lina Zhao ◽

Pengfei Li ◽

Fude Li ◽

Yongkun Yang ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Prognostic Value ◽

Metastatic Breast ◽

Breast Cancer Patients

POSEIDON Trial Phase 1b Results: Safety, Efficacy and Circulating Tumor DNA Response of the Beta Isoform-Sparing PI3K Inhibitor Taselisib (GDC-0032) Combined with Tamoxifen in Hormone Receptor Positive Metastatic Breast Cancer Patients

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-19-0508 ◽

2019 ◽

Vol 25 (22) ◽

pp. 6598-6605 ◽

Cited By ~ 4

Author(s):

Richard D. Baird ◽

Annelot G.J. van Rossum ◽

Mafalda Oliveira ◽

Karin Beelen ◽

Meiling Gao ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Metastatic Breast ◽

Circulating Tumor Dna ◽

Breast Cancer Patients ◽

Hormone Receptor Positive ◽

Phase 1B ◽

Tumor Dna ◽

Trial Phase

Abstract P1-20-06: Association of circulating tumor DNA with clinical outcomes in metastatic breast cancer patients

10.1158/1538-7445.sabcs18-p1-20-06 ◽

2019 ◽

Author(s):

AR Tan ◽

J Symanowski ◽

EN Kim ◽

M Hosking ◽

CD Morris ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Clinical Outcomes ◽

Metastatic Breast ◽

Circulating Tumor Dna ◽

Breast Cancer Patients ◽

Identifying Circulating Tumor DNA Mutation Profiles in Metastatic Breast Cancer Patients with Multiline Resistance

EBioMedicine ◽

10.1016/j.ebiom.2018.05.015 ◽

2018 ◽

Vol 32 ◽

pp. 111-118 ◽

Cited By ~ 24

Author(s):

Zhe-Yu Hu ◽

Ning Xie ◽

Can Tian ◽

Xiaohong Yang ◽

Liping Liu ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Metastatic Breast ◽

Circulating Tumor Dna ◽

Breast Cancer Patients ◽

Dna Mutation ◽

How to isolate and characterize EpCAMnegative circulating tumor cells in metastatic breast cancer patients

Geburtshilfe und Frauenheilkunde ◽

10.1055/s-0036-1593005 ◽

2016 ◽

Vol 76 (10) ◽

Author(s):

R Lampignano ◽

M Neumann ◽

B Behrens ◽

D Köhler ◽

D Niederacher ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Metastatic Breast ◽

Breast Cancer Patients

Vitamin D receptor status of circulating tumor cells (CTC) in metastatic breast cancer patients

Geburtshilfe und Frauenheilkunde ◽

10.1055/s-0036-1592738 ◽

2016 ◽

Vol 76 (10) ◽

Author(s):

X Zhang ◽

S Hofmann ◽

B Rack ◽

N Harbeck ◽

U Jeschke ◽

...

Keyword(s):

Breast Cancer ◽

Vitamin D ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Vitamin D Receptor ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Receptor Status